Latest News and Press Releases

RALEIGH, N.C., July 1, 2010 (GLOBE NEWSWIRE) -- On May 17, 2010, DARA BioSciences, Inc. (Nasdaq:DARA) issued a press release announcing that it had commenced an underwritten public offering of $10...

DARA was an Early Investor in SurgiVision and Presently Owns 1.6 Million Shares and Warrants to Purchase an Additional 405,000 Shares RALEIGH, N.C., June 28, 2010 (GLOBE NEWSWIRE) -- DARA...

RALEIGH, N.C., June 7, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARAD) announced today that Richard A. Franco, R.Ph., Chief Executive Officer and President, is scheduled to present at...

RALEIGH, N.C., June 1, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARAD) today announced that, on May 28 2010, NASDAQ notified the Company that it has regained compliance with the minimum...

RALEIGH, N.C., May 17, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (the "Company") (Nasdaq:DARAD) announced today that it has commenced an underwritten public offering of $10 million of units...

RALEIGH, N.C., May 12, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (the "Company") (Nasdaq:DARA) announced today that at the 2010 Annual Meeting of Stockholders, the Company's stockholders...

RALEIGH, N.C., April 27, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced today that on April 26, 2010, DARA Therapeutics, a subsidiary of DARA BioSciences, and the Division of...

RALEIGH, N.C., April 20, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced today that the company has been selected by the Scientific Programme Committee to present results from...

RALEIGH, N.C., March 25, 2010 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) announced that it has initiated a Phase I clinical study for DB959, its PPAR (peroxisome proliferator activated...

RALEIGH, N.C., March 19, 2010 (GLOBE NEWSWIRE) -- On March 16, 2010, DARA BioSciences, Inc. (Nasdaq:DARA) received notice from the Listing Qualifications Staff of The NASDAQ Stock Market LLC...